מיפג'ין

国: イスラエル

言語: ヘブライ語

ソース: Ministry of Health

有効成分:

MIFEPRISTONE

から入手可能:

A. LAPIDOT PHARMACEUTICALS, LTD

ATCコード:

G03XB01

医薬品形態:

טבליה

構図:

MIFEPRISTONE 200 MG

投与経路:

פומי

処方タイプ:

מרשם נדרש

製:

EXELGYNE LABORATORIES, FRANCE

治療群:

MIFEPRISTONE

治療領域:

MIFEPRISTONE

適応症:

Medical alternative to uterine suction for termination of intra-utrerine Pregnancy: - up to and no later than 49 days of amenorrhea (seven weeks) - in sequential use with a prostaglandin analogue misoprostol 400 mcg per os administered 36 to 48 hours after Mifegyne intake. Under these conditions the association of mifepristone and prostaglandins leads to a success rate of about 95 per cent of the cases. Preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reason (beyond the first trimester). Softening and dilatation of the cervix uteri prior to surgical termination of pregnancy during the first trimester.

承認日:

2014-07-31